Skip to main content

Robert McBurney
Accelerated Cure Project for MS

Robert McBurney joined the Accelerated Cure Project for Multiple Sclerosis as its Chief Executive in mid-2011 because he was compelled by the organization’s novel approach to catalyzing innovation in research towards a cure for MS.

He is a neuroscientist by training and has over 35 years of experience in biomedical research and in the management of research-based biotech companies. During the past 25 years, Robert has either founded or played leading roles in biotech companies in the US and in Europe, including Optimal Medicine, Theragenetics, BG Medicine, Differential Proteomics, CeNeS Pharmaceuticals and Cambridge NeuroScience. Many of those companies have focused on developing treatments for patients suffering from neurological disorders and mental illnesses. Others have developed predictive tests or clinical decision support systems for personalizing treatment and improving outcomes for individual patients.

Prior to joining the biotech industry, Robert held academic positions in medical schools in the United Kingdom and Australia, and research positions at Cambridge University and at the National Institutes of Health.

He currently serves on the Boards of Differential Proteomics, Inc., and Optimal Medicine, Ltd., both companies he co-founded, and is a Trustee of the Franklin W. Olin College of Engineering.


Precision Medicine Salon H-K
Marcia Kean (Feinstein Kean Healthcare), Kenneth Buetow (Arizona State University), Dave King (Exaptive), Robert McBurney (Accelerated Cure Project for MS)
The use of massive amounts of data to battle the major diseases of our time has so far generated only massive amounts of publicity. Can a new generation of cyberinfrastructure harness Big Data to transform our understanding of disease and truly combat these two public health challenges? Collaborators in the Data Liquidity Coalition believe they have the right approach to fulfill the promise. Read more.

For exhibition and sponsorship opportunities at Strata Rx conference, contact Sharon Pierce at (203) 304-9476 or

For information on trade opportunities with O'Reilly conferences email mediapartners

View a complete list of Strata Rx 2013 contacts